The scientific objective is to bring together the complementary experiences of quality laboratories to carry out an ambitious preclinical multidisciplinary research program in the field of regenerative medicine to design new treatments for degenerative diseases related mainly to age (cardiovascular diseases, osteoarticular diseases, fibrosis, hepatic cirrhosis, etc.).